Elisha W.  Finney net worth and biography

Elisha Finney Biography and Net Worth

Director of ICU Medical
Elisha Finney served as Executive Vice President, Finance and Chief Financial Officer of Varian Medical Systems (“Varian”) for 29 years. Ms. Finney joined Varian in 1988 and assumed a wide variety of finance functions over her 29 years with the company. Ms. Finney also serves on the Board of Directors of iRobot Corporation, NanoString Technologies and Mettler Toledo,  and has previously served on the Board of Directors of Cutera, Inc., Laserscope Inc., Thoratec Corporation, Altera Corporation, and Varex Imaging Corporation.

What is Elisha W. Finney's net worth?

The estimated net worth of Elisha W. Finney is at least $40,221.60 as of November 11th, 2024. Ms. Finney owns 240 shares of ICU Medical stock worth more than $40,222 as of November 21st. This net worth evaluation does not reflect any other assets that Ms. Finney may own. Learn More about Elisha W. Finney's net worth.

How do I contact Elisha W. Finney?

The corporate mailing address for Ms. Finney and other ICU Medical executives is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. ICU Medical can also be reached via phone at (949) 366-2183 and via email at [email protected]. Learn More on Elisha W. Finney's contact information.

Has Elisha W. Finney been buying or selling shares of ICU Medical?

Elisha W. Finney has not been actively trading shares of ICU Medical during the last ninety days. Most recently, Elisha W. Finney sold 300 shares of the business's stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $104.95, for a transaction totalling $31,485.00. Following the completion of the sale, the director now directly owns 2,129 shares of the company's stock, valued at $223,438.55. Learn More on Elisha W. Finney's trading history.

Who are ICU Medical's active insiders?

ICU Medical's insider roster includes Elisha Finney (Director), Vivek Jain (CEO & Chairman of the Board), George Lopez (Director), Virginia Sanzone (VP), Robert Swinney (Director), Christian Voigtlander (COO), and Daniel Woolson (Corporate Vice President and General Manager, Infusion Systems). Learn More on ICU Medical's active insiders.

Are insiders buying or selling shares of ICU Medical?

In the last year, insiders at the medical instruments supplier sold shares 14 times. They sold a total of 93,382 shares worth more than $12,985,151.66. The most recent insider tranaction occured on November, 1st when CEO Vivek Jain sold 12,000 shares worth more than $2,062,080.00. Insiders at ICU Medical own 6.7% of the company. Learn More about insider trades at ICU Medical.

Information on this page was last updated on 11/1/2024.

Elisha W. Finney Insider Trading History at ICU Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2024Sell300$104.95$31,485.002,129View SEC Filing Icon  
6/7/2023Sell194$190.41$36,939.541,481View SEC Filing Icon  
5/12/2022Sell217$170.53$37,005.011,933View SEC Filing Icon  
9/14/2021Sell2,424$242.20$587,092.8020,816View SEC Filing Icon  
8/13/2020Sell790$190.00$150,100.001,483View SEC Filing Icon  
See Full Table

Elisha W. Finney Buying and Selling Activity at ICU Medical

This chart shows Elisha W Finney's buying and selling at ICU Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ICU Medical Company Overview

ICU Medical logo
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Read More

Today's Range

Now: $167.59
Low: $164.25
High: $169.21

50 Day Range

MA: $176.54
Low: $167.59
High: $183.83

2 Week Range

Now: $167.59
Low: $82.82
High: $196.26

Volume

225,085 shs

Average Volume

235,508 shs

Market Capitalization

$4.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66